Sandra Parenti
Modena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model.
Journal: Blood cancer journal
Published: September 05, 2025
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis.
Journal: Journal of cellular and molecular medicine
Published: January 30, 2025
Targeting exhausted cytotoxic T cells through CTLA-4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts.
Journal: American journal of hematology
Published: March 28, 2024
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms.
Journal: Leukemia
Published: January 22, 2024
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms.
Journal: American journal of hematology
Published: June 13, 2023
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model.
Journal: Leukemia
Published: November 23, 2022
Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective.
Journal: International journal of molecular sciences
Published: October 28, 2022
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis.
Journal: Antioxidants (Basel, Switzerland)
Published: December 03, 2021
Magnesium favors the capacity of vitamin D3 to induce the monocyte differentiation of U937 cells.
Journal: Magnesium research
Published: December 03, 2021
Characterization of New ATM Deletion Associated with Hereditary Breast Cancer.
Journal: Genes
Published: December 22, 2020
Last Updated: 09/26/2026